[go: up one dir, main page]

FI118385B - Uusi menetelmä biologisesti aktiivisen proteiinin valmistamiseksi - Google Patents

Uusi menetelmä biologisesti aktiivisen proteiinin valmistamiseksi Download PDF

Info

Publication number
FI118385B
FI118385B FI970258A FI970258A FI118385B FI 118385 B FI118385 B FI 118385B FI 970258 A FI970258 A FI 970258A FI 970258 A FI970258 A FI 970258A FI 118385 B FI118385 B FI 118385B
Authority
FI
Finland
Prior art keywords
tgf
leu
ser
cys
protein
Prior art date
Application number
FI970258A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970258A (fi
FI970258A0 (fi
Inventor
Nico Cerletti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI970258A publication Critical patent/FI970258A/fi
Publication of FI970258A0 publication Critical patent/FI970258A0/fi
Application granted granted Critical
Publication of FI118385B publication Critical patent/FI118385B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI970258A 1994-07-25 1997-01-22 Uusi menetelmä biologisesti aktiivisen proteiinin valmistamiseksi FI118385B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP94810439 1994-07-25
EP94810439 1994-07-25
PCT/EP1995/002719 WO1996003433A1 (en) 1994-07-25 1995-07-12 New process for the production of biologically active protein
EP9502719 1995-07-12

Publications (3)

Publication Number Publication Date
FI970258A FI970258A (fi) 1997-01-22
FI970258A0 FI970258A0 (fi) 1997-01-22
FI118385B true FI118385B (fi) 2007-10-31

Family

ID=8218293

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970258A FI118385B (fi) 1994-07-25 1997-01-22 Uusi menetelmä biologisesti aktiivisen proteiinin valmistamiseksi

Country Status (19)

Country Link
US (1) US7057016B2 (zh)
EP (1) EP0779896B1 (zh)
JP (2) JPH11505404A (zh)
KR (1) KR100394532B1 (zh)
AT (1) ATE207934T1 (zh)
AU (1) AU699879B2 (zh)
CA (1) CA2194578A1 (zh)
DE (1) DE69523611T2 (zh)
DK (1) DK0779896T3 (zh)
ES (1) ES2166402T3 (zh)
FI (1) FI118385B (zh)
HU (1) HU222829B1 (zh)
IL (1) IL114702A (zh)
NO (1) NO317730B1 (zh)
NZ (1) NZ290374A (zh)
PT (1) PT779896E (zh)
TW (1) TW517059B (zh)
WO (1) WO1996003433A1 (zh)
ZA (1) ZA956139B (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997023638A1 (fr) * 1995-12-21 1997-07-03 Ajinomoto Co., Inc. Procede pour replier l'activine a humaine
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
US20030134292A1 (en) * 2001-10-30 2003-07-17 Farchaus Joseph W. Thermostable DNA polymerases and methods of making same
FR2871061B1 (fr) * 2004-06-04 2007-08-10 Coletica Sa Principe actif capable d'induire la transformation du tgbf- latent inactif en tgfb actif
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
EP1966229B1 (en) 2005-09-12 2015-10-21 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
WO2007033082A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
GB0604966D0 (en) * 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
JP5947721B2 (ja) 2009-10-30 2016-07-06 アベラ ファーマスーティカルズ インコーポレイテッド 変形性関節症を治療するためのジメチルスルホキシド（ｄｍｓｏ）およびメチルスルホニルメタン（ｍｓｍ）製剤
US10647777B2 (en) * 2014-05-28 2020-05-12 Genzyme Corporation Methods of controlling the formation of disulfide bonds in protein solutions
JP2016183118A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 増殖因子前駆体のリフォールディング方法
WO2018122794A1 (en) 2016-12-30 2018-07-05 Biogend Therapeutics Co., Ltd. Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof
TW202330579A (zh) * 2021-10-11 2023-08-01 高等教育聯邦系統 匹茲堡大學 經工程改造TGF-β單體及使用方法
GB2616476A (en) * 2022-03-11 2023-09-13 Multus Biotechnology Ltd Recombinant transforming growth factor beta 3 in yeast

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3168691D1 (en) * 1980-11-07 1985-03-14 Technicon Instr Immunoassay of proteins
US4620948A (en) 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (zh) 1982-12-22 1984-10-02 Genentech Inc
ATE85080T1 (de) 1984-02-17 1993-02-15 Genentech Inc Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.
US4572798A (en) 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
US4731440A (en) 1985-02-22 1988-03-15 Monsanto Company Method of somatotropin solubilization using dimethylsulfone and naturation
IL78197A (en) 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
GB8508340D0 (en) 1985-03-29 1985-05-09 Creighton T E Production of protein
EP0208539A3 (en) 1985-07-11 1988-08-03 Repligen Corporation Folding disulfide-cross-linkable proteins
US5453363A (en) 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
JPH0759598B2 (ja) * 1986-02-14 1995-06-28 藤沢薬品工業株式会社 ヒトインスリン様成長因子▲ｉ▼の製造法
NZ222168A (en) 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
NZ222569A (en) 1986-11-17 1990-08-28 Sandoz Ltd Production of glioblastoma-derived t cell suppressor factor (g-tsf) using recombinant techniques
FI100106B (fi) 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
US4931548A (en) 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
IL86090A (en) 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
WO1988008849A1 (en) 1987-05-11 1988-11-17 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
US5162507A (en) 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
EP0293785A3 (en) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Cloning and expression of simian transforming growth factor-ss1
US4985544A (en) 1987-08-04 1991-01-15 Kyowa Hakko Kogyo Co., Ltd. Process for renaturing fish growth hormone
US5061786A (en) * 1989-05-25 1991-10-29 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
US5144006A (en) * 1991-06-13 1992-09-01 The Rockefeller University Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides
AU2738392A (en) * 1991-11-11 1993-05-13 Ciba-Geigy Ag Novel hybrid transforming growth factors
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
TW440566B (en) * 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein

Also Published As

Publication number Publication date
IL114702A0 (en) 1995-11-27
WO1996003433A1 (en) 1996-02-08
IL114702A (en) 2005-03-20
JP2007082554A (ja) 2007-04-05
ES2166402T3 (es) 2002-04-16
ZA956139B (en) 1996-03-07
CA2194578A1 (en) 1996-02-08
HUT76667A (en) 1997-10-28
JPH11505404A (ja) 1999-05-21
HU222829B1 (hu) 2003-11-28
EP0779896B1 (en) 2001-10-31
AU3109695A (en) 1996-02-22
DE69523611T2 (de) 2002-06-20
PT779896E (pt) 2002-03-28
US7057016B2 (en) 2006-06-06
NO970326D0 (no) 1997-01-24
NO970326L (no) 1997-01-24
NO317730B1 (no) 2004-12-13
FI970258A (fi) 1997-01-22
DK0779896T3 (da) 2002-02-18
DE69523611D1 (de) 2001-12-06
EP0779896A1 (en) 1997-06-25
NZ290374A (en) 1998-07-28
AU699879B2 (en) 1998-12-17
FI970258A0 (fi) 1997-01-22
US20020115834A1 (en) 2002-08-22
KR100394532B1 (ko) 2003-10-22
ATE207934T1 (de) 2001-11-15
JP4354980B2 (ja) 2009-10-28
TW517059B (en) 2003-01-11

Similar Documents

Publication Publication Date Title
FI118385B (fi) Uusi menetelmä biologisesti aktiivisen proteiinin valmistamiseksi
FI103278B (fi) Menetelmä biologisesti aktiivisen TGF- :n kaltaisen proteiinin tuotta miseksi
JP2007031453A (ja) 生物学的に活性な二量体型タンパク質の製造のための新規の方法
NZ245047A (en) Hybrid transforming growth factor and recombinant dna encoding such a hybrid

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Ref document number: 118385

Country of ref document: FI